These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 24777850

  • 1. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome.
    de Wilde MA, Veltman-Verhulst SM, Goverde AJ, Lambalk CB, Laven JS, Franx A, Koster MP, Eijkemans MJ, Fauser BC.
    Hum Reprod; 2014 Jun; 29(6):1327-36. PubMed ID: 24777850
    [Abstract] [Full Text] [Related]

  • 2. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
    de Wilde MA, Goverde AJ, Veltman-Verhulst SM, Eijkemans MJ, Franx A, Fauser BC, Koster MP.
    Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
    [Abstract] [Full Text] [Related]

  • 3. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
    Hamdine O, Macklon NS, Eijkemans MJ, Laven JS, Cohlen BJ, Verhoeff A, van Dop PA, Bernardus RE, Lambalk CB, Oosterhuis GJ, Holleboom CA, van den Dool-Maasland GC, Verburg HJ, van der Heijden PF, Blankhart A, Fauser BC, Broekmans FJ, CETRO trial study group.
    Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
    [Abstract] [Full Text] [Related]

  • 4. Excess mortality in mothers of patients with polycystic ovary syndrome.
    Louwers YV, Roest-Schalken ME, Kleefstra N, Roeters van Lennep J, van den Berg M, Fauser BC, Bilo HJ, Sijbrands EJ, Laven JS.
    Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
    [Abstract] [Full Text] [Related]

  • 5. Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.
    Veltman-Verhulst SM, Goverde AJ, van Haeften TW, Fauser BC.
    Hum Reprod; 2013 Aug; 28(8):2228-34. PubMed ID: 23739218
    [Abstract] [Full Text] [Related]

  • 6. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [Abstract] [Full Text] [Related]

  • 7. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.
    Kuang H, Jin S, Hansen KR, Diamond MP, Coutifaris C, Casson P, Christman G, Alvero R, Huang H, Bates GW, Usadi R, Lucidi S, Baker V, Santoro N, Eisenberg E, Legro RS, Zhang H, Reproductive Medicine Network.
    Hum Reprod; 2015 Sep; 30(9):2222-33. PubMed ID: 26202922
    [Abstract] [Full Text] [Related]

  • 8. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O, Eijkemans MJ, Lentjes EW, Torrance HL, Macklon NS, Fauser BC, Broekmans FJ.
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [Abstract] [Full Text] [Related]

  • 9. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome.
    Veltman-Verhulst SM, van Haeften TW, Eijkemans MJ, de Valk HW, Fauser BC, Goverde AJ.
    Hum Reprod; 2010 Dec; 25(12):3123-8. PubMed ID: 20943702
    [Abstract] [Full Text] [Related]

  • 10. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X, Gissler M, Lavebratt C.
    Hum Reprod; 2022 May 30; 37(6):1311-1323. PubMed ID: 35348682
    [Abstract] [Full Text] [Related]

  • 11. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
    Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, Poort L, Cuypers WJSS, Beckers NGM, Broekmans FJM, Cohlen BJ, den Hartog JE, Fleischer K, Lambalk CB, Smeenk JMJS, Budding AE, Laven JSE.
    Hum Reprod; 2019 Jun 04; 34(6):1042-1054. PubMed ID: 31119299
    [Abstract] [Full Text] [Related]

  • 12. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L, Segers I, Belva F, Buyl R, Santos-Ribeiro S, Blockeel C, Smitz J, Anckaert E, Tournaye H, De Vos M.
    Hum Reprod; 2019 Aug 01; 34(8):1595-1607. PubMed ID: 31347678
    [Abstract] [Full Text] [Related]

  • 13. A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome.
    De Frène V, Vansteelandt S, T'Sjoen G, Gerris J, Somers S, Vercruysse L, De Sutter P.
    Hum Reprod; 2014 Oct 10; 29(10):2333-8. PubMed ID: 24963163
    [Abstract] [Full Text] [Related]

  • 14. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH, Lumsden MA, Fauser BC, Terrill P, Bestel E.
    Hum Reprod; 2014 Mar 10; 29(3):480-9. PubMed ID: 24457604
    [Abstract] [Full Text] [Related]

  • 15. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS).
    Ashrafi M, Sheikhan F, Arabipoor A, Hosseini R, Nourbakhsh F, Zolfaghari Z.
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct 10; 181():195-9. PubMed ID: 25150960
    [Abstract] [Full Text] [Related]

  • 16. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.
    Farland LV, Stern JE, Liu CL, Cabral HJ, Coddington CC, Diop H, Dukhovny D, Hwang S, Missmer SA.
    Hum Reprod; 2022 Oct 31; 37(11):2690-2699. PubMed ID: 36149255
    [Abstract] [Full Text] [Related]

  • 17. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE.
    J Clin Endocrinol Metab; 2023 Sep 18; 108(10):2447-2469. PubMed ID: 37580314
    [Abstract] [Full Text] [Related]

  • 18. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
    Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan MH.
    Hum Reprod; 2020 Jul 01; 35(7):1666-1674. PubMed ID: 32535629
    [Abstract] [Full Text] [Related]

  • 19. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, M Redman L, A Boyle J, Norman RJ, Mousa A, Joham AE, International PCOS Network.
    Fertil Steril; 2023 Oct 01; 120(4):767-793. PubMed ID: 37589624
    [Abstract] [Full Text] [Related]

  • 20. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE, International PCOS Network.
    Hum Reprod; 2023 Sep 05; 38(9):1655-1679. PubMed ID: 37580037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.